Routine SEC 6-K from Aurora Cannabis includes 18 June 2025 news release

Rhea-AI Filing Summary

Overview: Aurora Cannabis Inc. (ACB) filed a Form 6-K for the month of June 2025.

The filing is purely procedural and furnishes Exhibit 99.1—a news release dated 18 June 2025—without reproducing the release’s contents. No financial statements, earnings figures, or strategic transaction details are included. The cover page confirms that the company continues to file annual reports under Form 40-F and that Chief Executive Officer Miguel Martin signed the submission on 18 June 2025.

Investor takeaway: Because the underlying press release is not provided, this 6-K offers no quantitative data or substantive operational updates. It should therefore be viewed as routine compliance rather than a market-moving disclosure.

Insights

Financial Analyst

TL;DR: Routine 6-K cover; no material financial information—neutral impact.

The document merely notifies the SEC that Aurora Cannabis has furnished an external news release. Without the text of Exhibit 99.1, investors gain no insight into revenue, EBITDA, guidance, or strategic initiatives. As such, the filing does not alter the investment thesis, affect valuation models, or signal regulatory risk. The absence of substantive content leads to a neutral interpretation for capital markets.

 

 

  

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2025

Commission File No. 001-38691

AURORA CANNABIS INC. (Translation of registrant's name into English)

 

2207 90B St. SW
Edmonton, Alberta T6X 1V8
Canada
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F  ☐ Form 40-F  ☒

 

 

 

 

 

 

 

SUBMITTED HEREWITH

 

Exhibits		Description 
99.1	 	News release dated June 18, 2025

 

 

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AURORA CANNABIS INC.

/s/ Miguel Martin

 

Miguel Martin
Chief Executive Officer

Date: June 18, 2025

FAQ

What SEC document did Aurora Cannabis (ACB) file on 18 June 2025?

Aurora Cannabis submitted a Form 6-K, a current report for foreign private issuers.

Does the 6-K include any financial or earnings data for ACB?

No. The filing contains no financial statements or earnings figures.

Who signed the Form 6-K on behalf of Aurora Cannabis?

The report was signed by Miguel Martin, Chief Executive Officer.

What exhibit accompanies the Form 6-K?

Exhibit 99.1, described as a news release dated 18 June 2025, is furnished with the filing.

Is this filing likely to impact Aurora Cannabis’s stock price?

Given the lack of material information, the 6-K is considered routine and not market-moving.